Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 2017 Apr 10;174(9):911. doi: 10.1111/bph.13796

Retracted: Mice lacking the Raf‐1 kinase inhibitor protein exhibit exaggerated hypoxia‐induced pulmonary hypertension, by I Morecroft, B Doyle, M Nilsen, W Kolch, K Mair and MR MacLean. British Journal of Pharmacology, volume 163(5): 948–963, published in June 2011; DOI 10.1111/j.1476‐5381.2011.01305.x

PMCID: PMC6559205  PMID: 28397257

Abstract

The above article, published by the British Journal of Pharmacology in June 2011 (http://onlinelibrary.wiley.com/doi/10.1111/j.1476‐5381.2011.01305.x/full), has been retracted by agreement between the authors, the Journal Editor in Chief and John Wiley & Sons Ltd. Formal internal investigations by the British Journal of Pharmacology have concluded that inappropriate manipulation of western blots depicted in Figures 1, 8 and 9 has occurred. The non‐corresponding authors (M MacLean, B Doyle, K Mair, M Nilsen, W Kolch) wish to state that they had no knowledge that the figures in question had been manipulated. These issues are currently being investigated by the University of Glasgow. The retraction statement has also been approved by The University of Glasgow Research Integrity Council.

Reference

  1. Morecroft I, Doyle B, Nilsen M, Kolch W, Mair K and MacLean MR (2011). Mice lacking the Raf‐1 kinase inhibitor protein exhibit exaggerated hypoxia‐induced pulmonary hypertension. Brit J Pharmacol 163: 948–963. doi: 10.1111/j.1476-5381.2011.01305.x. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES